Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,758.00
(
0.34%
)
News Focus
News Focus
Post# of 257266
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

InTheTrenches

Send PM Follow Ignore
Followers 4
Posts 929
Boards Moderated 0
Alias Born 08/15/2006

InTheTrenches

Re: biomaven0 post# 101151

Monday, 08/09/2010 11:44:14 PM

Monday, August 09, 2010 11:44:14 PM

Post# of 257266
MNKD:

Recently re-filed their Afrezza (inhaled insulin) NDA.


Anyone here care to handicap their chances of:

- Getting FDA approval on Afrezza by the end of the year.

- Signing a deal on Afrezza before FDA review (they need money)

- Whether Afrezza, if approved, will go the way of Exubera (pulled from market by Pfizer after marketing failure)


No position, but taking a closer look.

TIA
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today